APA (7th ed.) Citation

Rampias, T., Gavrielatou, N., Panagiota, O., Kotsantis, I., Anastasiou, M., Pantazopoulos, A., . . . Psyrri, A. (2020). 962P Immunotherapeutic implications of mucin 1/16 expression in head and neck squamous cell carcinoma (HNSCC). Annals of Oncology, 31, S679. https://doi.org/10.1016/j.annonc.2020.08.1077

Chicago Style (17th ed.) Citation

Rampias, T., et al. "962P Immunotherapeutic Implications of Mucin 1/16 Expression in Head and Neck Squamous Cell Carcinoma (HNSCC)." Annals of Oncology 31 (2020): S679. https://doi.org/10.1016/j.annonc.2020.08.1077.

MLA (9th ed.) Citation

Rampias, T., et al. "962P Immunotherapeutic Implications of Mucin 1/16 Expression in Head and Neck Squamous Cell Carcinoma (HNSCC)." Annals of Oncology, vol. 31, 2020, p. S679, https://doi.org/10.1016/j.annonc.2020.08.1077.